City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

City of Hope CME - A Call to Action for Improved Thromboprophylaxis & Venous Thromboembolism Management

Skip Navigation

Global Navigation

 Contact CME

For additional information or questions about this module, please contact:

Department of Continuing Medical Education
City of Hope
 1500 East Duarte Road, Bldg 94
Duarte, CA 91010

E-mail: cme@coh.org
Fax: 626-301-8939
Phone:  626-256-4673, ext. 65622


 Software Requirements

The Web pages and Web-based applications require a minimum Web browser of Microsoft Internet Explorer 5.5 or higher, Mozilla 1.0 or higher, or another compatible Web browser. If you are not sure of the version of your browser, select Help in the menu bar of your browser, select About.

 A Call to Action for Improved Thromboprophylaxis & Venous Thromboembolism Management



Release date:
September 13, 2012
Expiration date: September 13, 2013
Estimated time to complete activity: 1 hour

To Obtain CME Credit:
Complete the post test and evaluation form
Submit to CME Dept via fax:626.301.8939 or email : cme@coh.org or mail: 1500 E. Duarte Rd, Bldg 94 Duarte CA 91010

Questions: 626.256.4673 ext 65622
Additional Resources:
Reading List

 Identified Need

VTE, including deep venous thrombosis (DVT) is a common and often fatal complication in patients with cancer. Data demonstrates that patients with cancer have the lowest rate of VTE prophylaxis in both inpatient and ambulatory settings.

Though proven, effective guidelines are available to prevent and treat DVT in such high risk patients, most who could benefit from such strategies do not benefit from them since too few health care professionals are aware of the evidence-based practices for identifying high risk patients and providing preventive, diagnostic or therapeutic services.

 Educational Objectives

Upon successful of this activity the learner should be better able to:

  • Evaluate the level of VTE risk for all patients with cancer
  • Discuss appropriate screening, monitoring and intervention strategies for reducing VTE in the oncology setting
  • Apply evidence-based updates to clinical practice guidelines and emerging research into treatment planning of VTE prophylaxis and management in patients
  • Describe management and clinical considerations for bleeding, renal impairment, thrombocytopenia, and other comorbidities when integrating VTE prophylaxis
  • Formulate strategies for those that transition to outpatient care in the oncology setting
  • Outline the various types of cultural diversities (gender, age, race, religion, culture, etc) that relate to demographics, diagnosis and treatment

 Target Audience

This activity has been designed to meet the needs of physicians, nurses and allied health care providers who treat patients with cancer.

 Accreditation Statement

The  City of Hope is accredited by the  Accreditation Council for Continuing Medical education to provide continuing medical education for physicians.

 Credit Designation

City of Hope designates this enduring material for a maximum of  1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

The following may apply CME Category 1 credit for license renewal:

Registered Nurses: Nurses may report up to 1 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number.

Physician’s Assistants: The National Commission on certification of Physicians Assistants states that AMA accredited Category 1 courses are acceptable fro CME requirements for recertification.

To receive CME credit, it is necessary to complete the post test & evaluation form. For more information, please click here.


 Disclosure Information

City of Hope has implemented policies and procedures to be in strict compliance with current ACCME Standards of Commercial Support requiring disclosure and resolution conflicts of interest.

Faculty Disclosure:
As part of these new commercial guidelines, we are required to disclose if Faculty , Presenters, Authors,  Planners, CME Committee Members, Course Directors and / or  Moderators have any real or apparent vested commercial interest(s) in both those companies whose products may be discussed/described during the course of the activity and in those companies who may be acting as commercial supporters of the activity.

Learn more >>

Disclosure of Off-Label Use: 
This activity may contain discussion of published and/or investigational uses of agents that are not approved/indicated by the US Food and Drug Administration (FDA).

Learn more >>

 Privacy Policy

City of Hope collect the information provided by the user. The information is used to provide CME certification  and to notify  users of up coming programs and education information that may be of interest to our users. The information is not shared with others for commercial purposes, unless the user has granted prior permission.

 Copyright

All rights reserved: for personal use only. No part of this presentation may be translated, reproduced or transmitted by any means or in any type of media form including electronic, mechanical photocopying, recording, broadcasting, or otherwise without prior permission from the publisher.

 Search

Go!
Advanced Search Options
News & Publications Search

 Method of Participation/ How to Obtain Credit

There are no fees for participating and receiving CME credit for this activity.

This activity is valid for CME credit from 
 September 13,  2012 to September 13, 2013.

During this period participants must:

  • Read the learning objectives and faculty disclosures
  • Study the educational material
  • Complete the post-test and evaluation form

Estimated time frame for completion of this activity, including the time to complete the post-test and evaluation form, is 1 hour.

 Medium

The internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.